Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tower Hill Capital Group is a private equity firm that specializes in middle-market investments, with a significant focus on the healthcare and life sciences sectors. The firm typically targets companies with strong management teams and sustainable competitive advantages, providing capital for growth, acquisitions, and recapitalizations. Within healthcare, Tower Hill has historically invested in healthcare services, medical products, and specialty pharmaceutical companies. Their approach involves active partnership with portfolio companies to drive operational improvements and strategic expansion. The firm is headquartered in New York and manages a diverse portfolio across multiple industries beyond healthcare, including business services and consumer products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tower Hill Capital Group.